Top stories in gastroenterology: Gastric cancer screening cost-effective, patients with IBS-C ‘dissatisfied’ with treatments

Among the top stories in gastroenterology is research that shows that endoscopic noncardia gastric cancer screening might be cost effective among high-risk ethnicities in the United States. A study demonstrating that patients with constipation predominant irritable bowel syndrome had dissatisfaction with treatment options, despite coping better than expected was also a top story.

Other top stories include research that showed that mailing fecal immunochemical tests directly to patients insured by Medicaid helped improve colorectal cancer screening rates, a Digestive Disease Week presentation on strategies for physician branding and an upcoming clinical trial that will test the safety and tolerability of a treatment for inflammatory bowel disease.

Gastric cancer screening cost-effective in some U.S. populations

Endoscopic noncardia gastric cancer screening might be cost effective among high-risk ethnicities in the United States, such as Hispanics, blacks and East Asians, despite low prevalence nationwide, according to research published in Gastroenterology. Read More.

Patients with IBS-C ‘dissatisfied’ with treatment options

Patients with constipation predominant irritable bowel syndrome expressed dissatisfaction with the available treatments for their symptoms, despite coping with their condition better than their doctors expected, according to survey results published in Advances in Therapy. Read More.

Small molecule IBD treatment begins phase 1 trial

A phase 1 clinical trial to test the safety and tolerability of BT-11, an investigational small molecule for the treatment of inflammatory bowel disease, is currently under way. Read More.

Physician Branding 101: Know your why, use goals to drive strategy

Physicians should push their own brand or the brand of their organization with full awareness of the goal and the appropriate strategy in place, according to a social media expert at Digestive Disease Week 2018. Read More.

Mailed fecal immunochemical test kits nearly double colon cancer screening rates

Mailing fecal immunochemical tests directly to patients insured by Medicaid helped improve colorectal cancer screening rates, according to research published in Cancer. Read More.